Provider of Trump Covid drug is president's golf friend Link to drug company boss raises questions about ‘cure’ claims and exclusive access.
New questions have emerged over the circumstances in which Donald Trump was given an experimental antibody drug cocktail produced by a golfing acquaintance to treat his coronavirus infection. As Trump wrongly hailed his treatment – which included a drug called REGN-COV2 produced by Regeneron – as a “cure”, it emerged that the company’s chief executive, Leonard Schleifer, is a member of the Trump National golf club in Briarcliff Manor, New York, and had met the president in May to talk about drugs his company was developing. While some ethicists have defended Trump’s privileged access as president to experimental treatments, others have suggested it raises questions of fairness among other concerns, including his history of touting unproven treatments. Trump’s relationship with Schleifer, whom he reportedly calls “Lenny”, adds to growing questions over the president’s almost exclusive access to experimental treatments unavailable to most other Americans, even as he has continued to downplay the threat of coronavirus based on his own experience. The price of Regeneron stocks – which Trump has owned in the past – soared after it was revealed the drug had been made available for his treatment and Trump stated it would be made freely available for all, although he didn’t explain how.
News 
Market Data 
Discover 
AI
